U.S., March 12 -- An application to own the trademark for 'DYSPLASIX' has been filed on Aug. 07, 2024.
Owner(s):
Amplexd Therapeutics, Inc.; Suite 200, 9841 Washingtonian Boulevard, Maryland
Goods and/or Services:
For: Vaginal suppositories for treatment of cervical cancer and precursors to cervical cancer including high-risk human papillomaviruses; topical ointment for treatment of vulvar cancer and precursors to vulvar cancer including high-risk human papillomaviruses; topical ointment for treatment of penile cancer and precursors to penile cancer including high-risk human papillomaviruses; topical ointment, and oral rinse for head and neck cancers and precursors to head and neck cancer including high-risk human papillomaviruses; anal...